Erratum: Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, tnfa related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats (PLoS ONE (2014) 9:9 (e107220) DOI 10.1371/journal.pone.0107220);Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Pal, Pabitra Bikash ^a   Sinha, Krishnendu ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CASPASE 3; CASPASE 8; CASPASE 9; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITROGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C EPSILON; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UREA; URIC ACID; ADVANCED GLYCATION END PRODUCT; ANTIOXIDANT; APOPTOSIS REGULATORY PROTEIN; GLUCOSE BLOOD LEVEL; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; STREPTOZOCIN; XANTHINE OXIDASE; XANTHONE DERIVATIVE;

ADULT; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY HYPERTROPHY; KIDNEY MASS; MALE; MITOCHONDRION; NONHUMAN; OPTIMAL DRUG DOSE; OXIDATIVE STRESS; RAT; RENAL PROTECTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WISTAR RAT; ANIMAL; BIOSYNTHESIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GLOMERULUS; METABOLISM; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

RATTUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HYDROXYPROLINE; HYPERGLYCEMIA; KIDNEY GLOMERULUS; MALE; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OXIDATIVE STRESS; PROTEIN KINASE C; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; XANTHINE OXIDASE; XANTHONES;

EID: 84907215623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115364     Document Type: Erratum

References (72)

1. Bonnefont-Rousselot D, Beaudeux JL, Therond P, Peynet J, Legrand A, et al. (2004) Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 62: 147-157.
2. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50: 537-546.
3. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes. Diabetes 57: 1446-1454.
4. Yan HD, Li XZ, Xie JM, Li M (2007) Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells. Chin Med J 120: 787-793.
5. Ibrahim HN, Hostetter TH (1997) Diabetic nephropathy. J Am Soc Nephrol 8: 487-493.
6. Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, et al. (2009) Diabetic nephropathy. Diabetol Metab Syndr 21: 1-10.
7. Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, et al. (2011) Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. Mol Nutr Food Res 55: 1655-1665.
8. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
9. Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812: 719-731.
10. Das J, Sil PC (2012) Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 43: 1509-1523.
11. Ghosh J, Das J, Manna P, Sil PC (2009) Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection. Free Radical Biol Med 48: 535-553.
12. Manna P, Ghosh J, Das J, Sil PC (2010) Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IκBα/NFκB, MAPKs and mitochondria dependent pathways: Prophylactic role of arjunolic acid. Free Radical Biol Med 48: 1465-1484.
13. Ghosh J, Das J, Manna P, Sil PC (2010) Protective effect of the fruits of Terminalia arjuna against cadmium-induced oxidant stress and hepatic cell injury via MAPK activation and mitochondria dependent pathway. Food Chem 123: 1062-1075.
14. Pal S, Pal PB, Das J, Sil PC (2011) Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxycology 283: 129-139.
15. Chatterjee M, Sil PC (2006) Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo. Indian J Biochem Biophy 43: 299-305.
16. Bhattacharjee R, Sil PC (2007) Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties. Food Chem Toxicol 45: 817-826.
17. Sarkar MK, Kinter M, Mazumder B, Sil PC (2009) Purification and characterization of a novel antioxidant protein molecule from Phyllanthus niruri. Food Chem 111: 1405-1412.
18. Bhattacharyya S, Pal PB, Sil PC (2013) A 35 kD Phyllanthus niruri protein modulates iron mediated oxidative impairment to hepatocytes via the inhibition of ERKs, p38 MAPKs and activation of PI3k/Akt pathway. Food Chem Toxicol 56: 119-30.
19. Bhattacharjee S, Ghosh S, Sil PC (2014) Amelioration of aspirin induced oxidative impairment and apoptotic cell death by a novel antioxidant protein molecule isolated from the herb Phyllanthus niruri. PLoS One 9: e89026.
20. 4induced renal oxidative impairments and necrotic cell death. Pathophysiology 19: 101-114.
21. Sarkar K, Ghosh A, Kinter M, Mazumder B, Sil PC (2006) Purification and characterization of a 43 kD hepatoprotective protein from the herb Cajanus indicus L. Protein J 25: 411-421.
22. Manna P, Sinha M, Sil PC (2007) A 43 kD protein isolated from the herb Cajanus indicus L attenuates sodium fluoride-induced hepatic and renal disorders in vivo. J Biochem Mol Biol 40: 382-395.
23. Ghosh A, Sil PC (2009) Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-κB pathway: Role of a novel plant protein. Chem Biol Interact 177: 96-106.
24. Pal S, Sil PC (2012) A 43 kD protein from the leaves of the herb Cajanus indicus L. modulates doxorubicin induced nephrotoxicity via MAPKs and both mitochondria dependent and independent pathways. Biochimie 94: 1356-67.
25. Pal S, Ahir M, Sil PC (2012) Doxorubicin-induced neurotoxicity is attenuated by a 43-kD protein from the leaves of Cajanus indicus L. via NF-κB and mitochondria dependent pathways. Free Radic Res 46: 785-98.
26. Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB (1995) The relative antioxidant activities of plant derived polyphenolic flavonoids. Free Radic Res 22: 375-383.
27. Matkowski A, Kus̈ P, Góralska E, Woźniak D (2013) Mangiferin-a bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev Med Chem 13: 439-55.
28. Aritomi M, Kawasaki T (1969) A new xanthone C-glucoside, position isomer of mangiferin, from Anemarrhena asphodeloides Bunge. Tetrahedron Lett 12: 941-944.
29. Aderibigbe AO, Emudianughe TS, Lawal BA (1999) Antihyperglycaemic effect of Mangifera indica in rat. Phytother Res 13: 504-507.
30. Sairam K, Hemalatha S, Kumar A, Srinivasan T, Ganesh J, et al. (2003) Evaluation of anti-diarrhoeal activity in seed extracts of Mangifera indica. J Ethnopharmacol 84: 11-15.
31. Yoshimi N, Matsunaga K, Katayama M, Yamada Y, Kuno T, et al. (2001) The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats. Cancer Lett 163: 163-170.
32. Garcia D, Escalante M, Delgado R, Ubeira FM, Leiro J (2003) Anthelminthic and antiallergic activities of Mangifera indica L. stem bark components Vimang and mangiferin. Phytother Res 17: 1203-1208.
33. Guha S, Ghosal S, Chattopadhyay U (1996) Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone. Chemotherapy 42: 443-451.
34. Bairy I, Reeja S, Siddharth RPS, Bhat M, Shivananda PG (2002) Evaluation of antibacterial activity of Mangifera indica on anaerobic dental microflora based on in vivo studies. Indian J Pathol Microbiol 45: 307-310.
35. Das J, Ghosh J, Roy A, Sil PC (2012) Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFkB pathways. Toxicol Appl Pharmacol 260: 35-47.
36. Pal PB, Sinha K, Sil PC (2013) Mangiferin, a natural xanthone, protects murine liver in Pb(II) induced hepatic damage and cell death via MAP kinase, NF-κB and mitochondria dependent pathways. PLoS One 8: e56894.
37. Sinha K, Pal PB, Sil PC (2013) Mangiferin, a naturally occurring xanthone Cglycoside, ameliorates lead (Pb)-induced murine cardiac injury via mitochondria-dependent apoptotic pathways. Signpost Open Access J Org Biomol Chem 1: 47-63.
38. Ghosh M, Das J, Sil PC (2012) D(+) galactosamine induced oxidative and nitrosative stress-mediated renal damage in rats via NF-κB and inducible nitric oxide synthase (iNOS) pathways is ameliorated by a ployphenol xanthone, mangiferin. Free Rad Res 46: 116-32.
39. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
40. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421.
41. Uchida K, Stadtman ER (1993) Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J Biol Chem 268: 6388-6393.
42. LeBel CP, Bondy SC (1990) Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Int 17: 435-440.
43. Kim JD, McCarter RJM, Yu BP (1996) Influence of age, exercise and dietary restriction on oxidative stress in rats. Aging Clin Exp Res 8: 123-129.
44. Lara LS, McCormac M, Semprum-Prieto LC, Shenouda S, Majid DS, Kobori H, Navar LG, Prieto MC (2012) AT1 receptor mediated augmentation of angiotensiongen, oxidative stress, and inflammation in ANGII-salt hypertension. Am J Physiol Renal Physiol 302(1): F85-94.
45. Pal PB, Pal S, Das J, Sil PC (2012) Modulation of mercury-induced mitochondria-dependent apoptosis by glycine in hepatocytes. Amino Acids 42: 1669-83.
46. Ellman GL (1959) Tissue sulphydryl group. Arch Biochem Biophys 82: 70-77.
47. Hissin PJ, Hilf RA (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226.
48. Woessner JF (1961) The determination of hydroxyproline in tissueand protein samples containing small proportions of this iminoacid. Arch Biochem Biophys 93: 440-447.
49. Sellins KS, Cohen JJ (1987) Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199-3206.
50. Das J, Sil PC (2012) Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stressrelated signaling pathways and apoptosis in rats. Amino Acids 43: 1509-23.
51. Das J, Vasan V, Sil PC (2012) Taurine exerts hypoglycemic effect in alloxaninduced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis. Toxicol Appl Pharm 258: 296-308.
52. Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48: 1-9.
53. Chen HC, Guh JY, Chang JM, Hsieh MC, Shin SJ, et al. (2005) Role of lipid control in diabetic nephropathy. Kidney Int Suppl 94: S60-2.
54. Lee WC, Chen HC, Wang CY, Lin PY, Ou TT, et al. (2010) Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-β and NF-κB. Biosci Biotechnol Biochem 74: 1355-1361.
55. Li X, Cui X, Sun X, Li X, Zhu Q, et al. (2010) Mangiferin Prevents Diabetic Nephropathy Progression in Streptozotocin-Induced Diabetic Rats. Phytother Res 24: 893-899.
56. Miural T, Ichiki H, Hashimotol I, Iwamotol N, Katol M, et al. (2001) Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine 8: 85-87.
57. Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK (2002) Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 176: 165-173.
58. Mishra B, Priyadarsini IK, Sudheerkumar M, Unnikrishhnan MK, Mohan H (2006) Pulse radiolysis studies of mangiferin: A C-glycosyl xanthone isolated from Mangifera indica. Rad Phys Chem 75: 70-77.
59. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V (2001) Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 107: 217-224.
60. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, et al. (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100: 2995-2999.
61. Dunlop ME, Muggli EE (2000) Small heat shock protein alteration provide a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int 57: 464-475.
62. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H (2003) Reactive oxygen speciesregulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14: S241-S245.
63. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB (2002) Role of high glucoseinduced nuclear factor-KB activation in monocyte chemoattractant protein-I expression by mesangial cells. J Am Soc Nephrol 13: 894-902.
64. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, et al. (2003) Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 278: 36916-36923.
65. Shah SV, Baliga R, Rajapurkar M, Fonseca VA (2007) Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28.
66. Wolf G, Ziyadeh FN (1999) Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405.
67. Park IS, Kiyomoto H, Abboud SL Abboud, HE (1997) Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46: 473-480.
68. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290.
69. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, et al. (1998) Two CD95 (APO-1/Fas) signaling pathways. Embo J 17: 1675-87.
70. Sinha K, Pal PB, Sil PC (2014) Cadmium (Cd2+) exposure differentially elicits both cell proliferation and cell death related responses in SK-RC-45. Toxicol in Vitro 28: 307-318.
71. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-90.
72. Lawen A (2003) Apoptosis-an introduction. BioEssays 25: 888-896.